Effects of baicalein isolated from roots of Scutellaria baicalensis Georgi on interleukin 1 beta- and tumour necrosis factor alpha-induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 production in cultured human umbilical vein endothelial cells

被引:0
|
作者
Kimura, Y [1 ]
Okuda, H [1 ]
Hayashi, KY [1 ]
Matsushita, N [1 ]
机构
[1] SUMITOMO MET IND LTD,PHARMACOL LAB,NEW DRUG RES DEPT,HIGH QUAL LIFE RES LABS,BIOMED DIV,KYOTO 61902,JAPAN
关键词
interleukin; 1; beta; tumour necrosis factor-alpha; tissue-type plasminogen activator; plasminogen activator inhibitor-1; human umbilical vein endothelial cells;
D O I
10.1002/(SICI)1099-1573(199708)11:5<363::AID-PTR106>3.3.CO;2-L
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The effects were examined of baicalein on tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) production stimulated by interleukin-1 alpha (IL-1 beta) and tumour necrosis factor-alpha (TNP-alpha) in cultured human vein umbilical endothelial cells (HUVECs), IL-1 beta and TNF-alpha increased PAI-1 production, but they decreased t-PA production, Baicalein isolated from the roots of Scutellaria baicalensis Georgi, inhibited the PAI-1 production stimulated by IL-1 beta and TNF-alpha, but it had no effect on the t-PA, In addition, protein kinase C (PKC) inhibitors such as H7 and sphingosine decreased the reduction of t-PA and the increase of PAI-1 by IL-1 beta and TNF-alpha. On the other hand, dibutryl cAMP and forskolin had no effect on the t-PA reduction and PAI-1 increase by IL-1 beta and TNF-alpha. Moreover, IL-1 beta and TNF-alpha did not cause [Ca2+] elevation. These results suggest that the inhibitory action of baicalein on the PAI-1 production by both cytokines might be directly mediated through PKC inhibition. (C) 1997 by John Wiley & Sons, Ltd.
引用
收藏
页码:363 / 367
页数:5
相关论文
共 50 条
  • [21] GENISTEIN REDUCES TUMOR-NECROSIS-FACTOR ALPHA-INDUCED PLASMINOGEN-ACTIVATOR INHIBITOR-1 TRANSCRIPTION BUT NOT UROKINASE EXPRESSION IN HUMAN ENDOTHELIAL-CELLS
    VANHINSBERGH, VWM
    VERMEER, M
    KOOLWIJK, P
    GRIMBERGEN, J
    KOOISTRA, T
    BLOOD, 1994, 84 (09) : 2984 - 2991
  • [22] Glycation does not alter LDL-induced secretion of tissue plasminogen activator and plasminogen activator inhibitor-1 from human aortic endothelial cells
    Klein, RL
    Semler, AJ
    Baynes, JW
    Thorpe, SR
    Lyons, TJ
    Jenkins, AJ
    MAILLARD REACTION: CHEMISTRY AT THE INTERFACE OF NUTRITION, AGING, AND DISEASE, 2005, 1043 : 379 - 389
  • [23] ENHANCED TISSUE FACTOR ACTIVITY AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGEN IN HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS INCUBATED WITH LIPOPROTEINS
    KANEKO, T
    WADA, H
    WAKITA, Y
    MINAMIKAWA, K
    NAKASE, T
    MORI, Y
    DEGUCHI, K
    SHIRAKAWA, S
    BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (03) : 385 - 392
  • [24] INTERLEUKIN-1 AND LIPOPOLYSACCHARIDE INDUCE AN INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR INVIVO AND IN CULTURED ENDOTHELIAL-CELLS
    EMEIS, JJ
    KOOISTRA, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (05): : 1260 - 1266
  • [25] Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells
    Nishimura, H
    Tsuji, H
    Masuda, H
    Nakagawa, K
    Nakahara, Y
    Kitamura, H
    Kasahara, T
    Sugano, T
    Yoshizumi, M
    Sawada, S
    Nakagawa, M
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (06) : 1189 - 1195
  • [26] IL-8 induces imbalances between nitric oxide and endothelin-1, and also between plasminogen activator inhibitor-1 and tissue-type plasminogen activator in cultured endothelial cells
    Cheng, Min
    Li, Yi
    Wu, Jiang
    Nie, Yongmei
    Li, Liang
    Liu, Xiaojing
    Charoude, Hojjatollah Nozad
    Chen, Huaiqing
    CYTOKINE, 2008, 41 (01) : 9 - 15
  • [27] SECRETION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FROM CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS IS INDUCED BY VERY LOW-DENSITY-LIPOPROTEIN
    STIKORAHM, A
    WIMAN, B
    HAMSTEN, A
    NILSSON, J
    ARTERIOSCLEROSIS, 1990, 10 (06): : 1067 - 1073
  • [28] SYNTHESIS AND SECRETION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 BY HUMAN ENDOTHELIAL-CELLS INVITRO - EFFECT OF ACTIVE-SITE MUTAGENIZED TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    BARTHA, K
    DECLERCK, PJ
    MOREAU, H
    NELLES, L
    COLLEN, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (02) : 792 - 797
  • [29] Effects of cadmium on the release of tissue plasminogen activator and plasminogen activator inhibitor type 1 from cultured human vascular smooth muscle cells and fibroblasts
    Yamamoto, C
    Kaji, T
    Sakamoto, M
    Kozuka, H
    TOXICOLOGY, 1996, 106 (1-3) : 179 - 185
  • [30] Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism
    Wahrenberg, H
    Wennlund, A
    Hoffstedt, J
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 146 (05) : 607 - 611